drugstore.com, inc. to Announce Third Quarter 2008 Results During Conference Call...

* Reuters is not responsible for the content in this press release.

Thu Oct 23, 2008 4:18pm EDT 

drugstore.com, inc. to Announce Third Quarter 2008 Results During Conference
Call on Wednesday, November 5, 2008 at 5:00 p.m. ET

BELLEVUE, Wash., Oct. 23 /PRNewswire-FirstCall/ -- drugstore.com, inc.
(Nasdaq: DSCM), a leading online provider of health, beauty, vision, and
pharmacy products, will announce its financial results for the third quarter
2008 during a conference call on Wednesday, November 5, 2008 at 5:00 p.m. ET
(2:00 p.m. PT).  A press release of the third quarter 2008 earnings will be
distributed via PR Newswire and posted on the drugstore.com(TM) Web site at
http://www.investor.drugstore.com.
    (Logo:  http://www.newscom.com/cgi-bin/prnh/20070813/AQM043LOGO)
    The conference call will also be broadcast live over the Internet and will
be accessible through replays for 60 days on the drugstore.com(TM) Web site at
http://www.investor.drugstore.com, by clicking on the "audio" hyperlink.
    About drugstore.com, inc.
    drugstore.com, inc. (NASDAQ: DSCM) is a leading online provider of health,
beauty, vision, and pharmacy products. Our portfolio of brands includes:
drugstore.com(TM), Beauty.com(TM) and VisionDirect.com(TM). All are accessible
from http://www.drugstore.com and provide a convenient, private, and
informative shopping experience while offering a wide assortment of more than
40,000 products at competitive prices.
    The drugstore.com pharmacy is certified by the National Association of
Boards of Pharmacy (NABP) as a Verified Internet Pharmacy Practice Site
(VIPPS) and operates in compliance with federal and state laws and regulations
in the United States.
     Contact:
     Investor Relations:
     Brinlea Johnson
     212-551-1453
     brinlea@blueshirtgroup.com

SOURCE  drugstore.com, inc.

Investor Relations, Brinlea Johnson, +1-212-551-1453
brinlea@blueshirtgroup.com, for drugstore.com, inc.
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.